Lanying Du Selected Research

Severe Acute Respiratory Syndrome

10/2021	Neutralizing antibodies for the prevention and treatment of COVID-19.
1/2021	Learning from the past: development of safe and effective COVID-19 vaccines.
11/2020	Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
7/2020	Yeast-Expressed SARS-CoV Recombinant Receptor-Binding Domain (RBD219-N1) Formulated with Aluminum Hydroxide Induces Protective Immunity and Reduces Immune Enhancement.
1/2014	Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.
12/2012	Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome.
8/2012	Receptor-binding domains of spike proteins of emerging or re-emerging viruses as targets for development of antiviral vaccines.
4/2010	A 219-mer CHO-expressing receptor-binding domain of SARS-CoV S protein induces potent immune responses and protective immunity.
3/2008	Priming with rAAV encoding RBD of SARS-CoV S protein and boosting with RBD-specific peptides for T cell epitopes elevated humoral and cellular immune responses against SARS-CoV infection.
1/2008	Development of subunit vaccines against severe acute respiratory syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lanying Du Research Topics

Disease

55	Infections 01/2022 - 08/2006
14	COVID-19 10/2022 - 01/2020
13	Severe Acute Respiratory Syndrome 10/2021 - 08/2006
12	Virus Diseases (Viral Diseases) 11/2021 - 01/2005
11	Human Influenza (Influenza) 02/2015 - 09/2008
8	Coronavirus Infections 01/2020 - 01/2015
6	Zika Virus Infection 11/2021 - 01/2017
6	Influenza in Birds (Avian Flu) 01/2015 - 07/2010
3	Acute Lung Injury 04/2018 - 10/2011
3	Lung Injury 01/2018 - 01/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2017 - 08/2015
2	Poisoning 01/2018 - 10/2011
2	Acquired Immunodeficiency Syndrome (AIDS) 06/2017 - 08/2015
1	Respiratory Insufficiency (Respiratory Failure) 04/2018
1	Cytokine Release Syndrome 01/2018
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2018
1	Body Weight (Weight, Body) 12/2017
1	Type 2 Diabetes Mellitus (MODY) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Diarrhea 11/2016
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 03/2016
1	Respiratory Syncytial Virus Infections 02/2015
1	Viral Pneumonia 02/2015
1	Hepatocellular Carcinoma (Hepatoma) 06/2014
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2014
1	Intestinal Volvulus (Volvulus) 01/2012
1	Fever (Fevers) 09/2008

Drug/Important Bio-Agent (IBA)

44	VaccinesIBA 01/2022 - 09/2006
33	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2005
18	Neutralizing AntibodiesIBA 11/2021 - 09/2006
11	AntibodiesIBA 10/2022 - 01/2013
10	Subunit VaccinesIBA 01/2019 - 01/2008
9	Antiviral Agents (Antivirals)IBA 01/2022 - 07/2010
7	Recombinant ProteinsIBA 11/2020 - 09/2008
6	Monoclonal AntibodiesIBA 10/2021 - 03/2010
6	EpitopesIBA 01/2019 - 03/2008
5	Pharmaceutical PreparationsIBA 01/2021 - 12/2015
5	Peptides (Polypeptides)IBA 04/2020 - 03/2008
4	Complement System Proteins (Complement)IBA 04/2018 - 10/2011
4	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2017 - 01/2013
3	Immunoglobulin G (IgG)IBA 01/2018 - 08/2013
2	Messenger RNA (mRNA)IBA 10/2022 - 06/2014
2	GossypolIBA 01/2022 - 11/2019
2	SARS-CoV-2 spike proteinIBA 10/2021 - 04/2020
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 07/2020
2	Immune Sera (Antisera)IBA 01/2020 - 08/2013
2	CytokinesIBA 04/2018 - 01/2014
2	ParaquatIBA 01/2018 - 10/2011
2	Hemagglutinins (Hemagglutinin)IBA 12/2017 - 06/2013
2	HIV Protease InhibitorsIBA 01/2017 - 08/2015
2	Nelfinavir (Viracept)FDA Link 01/2017 - 08/2015
2	InterferonsIBA 12/2015 - 01/2014
2	HIV Fusion InhibitorsIBA 08/2015 - 08/2013
2	Human Serum Albumin FDA LinkGeneric 02/2015 - 08/2013
2	AntigensIBA 06/2014 - 09/2008
2	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2011 - 07/2010
2	Recombinant Fusion ProteinsIBA 01/2011 - 10/2010
1	mRNA VaccinesIBA 10/2022
1	Single-Domain AntibodiesIBA 01/2022
1	Lipid NanoparticlesIBA 01/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 10/2021
1	EnzymesIBA 10/2021
1	NanovaccinesIBA 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	SolutionsIBA 11/2020
1	Protein SIBA 07/2020
1	LipopeptidesIBA 04/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	Fc Receptors (Fc Receptor)IBA 01/2020
1	Polysaccharides (Glycans)IBA 01/2019
1	ChemokinesIBA 04/2018
1	vilobelimabIBA 01/2018
1	4Dm2mIBA 06/2017
1	Broadly Neutralizing AntibodiesIBA 01/2017
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2017
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 11/2016
1	MF59 oil emulsionIBA 03/2016
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 12/2015
1	Cadherins (E-Cadherin)IBA 10/2015
1	Enfuvirtide (Fuzeon)FDA Link 08/2015
1	Palivizumab FDA Link 02/2015
1	Maleic Anhydrides (Maleic Anhydride)IBA 02/2015
1	MicroRNAs (MicroRNA)IBA 06/2014
1	Hepatocyte Nuclear FactorsIBA 06/2014
1	ADS J1IBA 05/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014
1	Monocyte Chemoattractant ProteinsIBA 01/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	avian influenza A virus hemagglutininIBA 10/2013
1	3-hydroxyphthalic anhydrideIBA 08/2013
1	HA 7IBA 02/2013
1	3- fluoro- N- (2- (1- piperidinyl)ethyl)- 5- (trifluoromethyl)benzamideIBA 06/2011
1	Viral HemagglutininsIBA 06/2011
1	piperidineIBA 06/2011
1	Protein Subunit VaccinesIBA 07/2010
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2008

Therapy/Procedure

18	Therapeutics 01/2022 - 04/2010
1	Intranasal Administration 02/2015